Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-05 · accession 0001439222-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-09 | 2024-01-09 | AGIO | Burns James William | CLO | S - Sale+OE | $22.99 | -1,163 | 26.3K | -4% | -$26.7K |
| D | 2024-01-09 | 2024-01-05 | AGIO | Burns James William | CLO | M - OptEx | $0.00 | +3,250 | 27.5K | +13% | $0 |
| D | 2024-01-09 | 2024-01-05 | AGIO | Burns James William | CLO | M - OptEx | $0.00 | -3,250 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-01-09 | S | D | 1,163 | $22.99 | 26,336 | D | — | — | |
| 2 | Common | Common stock | 2024-01-05 | M | A | 3,250 | $0.00 | 27,499 | D | — | — | (F1) Includes 359 shares purchased through the Company's employee stock purchase plan. |
| 3 | Derivative | Performance share units | 2024-01-05 | M | D | 3,250 | $0.00 | 0 | D | — · — to — | 3,250 Common stock | (F3) Each performance share unit represents a contingent right to receive one share of the issuer's common stock. (F4) The PSUs were granted on February 10, 2021. The PSUs vest upon the achievement of a specified clinical milestone. The performance criteria for the specified clinical milestone was determined to have been met on January 5, 2024, resulting in the vesting of the PSUs. Vested shares will be delivered to the reporting person within three business days after such shares become vested. |